TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vitrolife AB
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 3,059,082 | 1,639,157 | 1,304,863 |
Financial expenses | 112,564 | 10,481 | 14,157 |
Earnings before taxes | 507,955 | 448,572 | 383,622 |
EBITDA | 993,208 | 495,370 | |
Total assets | 19,439,451 | 18,947,393 | 2,414,815 |
Current assets | 1,487,921 | 1,371,749 | 1,481,772 |
Current liabilities | 587,412 | 930,680 | 185,439 |
Equity capital | 15,830,794 | 14,942,525 | 2,108,371 |
- share capital | 26,486 | 26,946 | 23,198 |
Employees (average) | 1,117 | 478 | 405 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 81.4% | 78.9% | 87.3% |
Turnover per employee | 2,739 | 3,429 | 3,222 |
Profit as a percentage of turnover | 16.6% | 27.4% | 29.4% |
Return on assets (ROA) | 3.2% | 2.4% | 16.5% |
Current ratio | 253.3% | 147.4% | 799.1% |
Return on equity (ROE) | 3.2% | 3.0% | 18.2% |
Change turnover | 1,469,188 | 424,448 | -245,725 |
Change turnover % | 92% | 35% | -16% |
Chg. No. of employees | 639 | 73 | 7 |
Chg. No. of employees % | 134% | 18% | 2% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.